Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Acute Mania in Bipolar Disorder
Interventions
DRUG

Quetiapine Fumarate

"Oral treatment, twice daily. 100 mg/day at Day 1, 200 mg/day at Day 2, 300 mg/day at Day 3, 400 mg/day at Day 4, from 400 mg/day to 600 mg/day before Day 8, from 600 mg/day to 800 thereafter, judged by the investigator.~Tablets"

DRUG

Lithium

Oral treatment, twice daily. 250 mg/day to 2000mg/day from Day1 to Day 7, 500mg/day to 2000mg/day thereafter, judged by the investigator.

Trial Locations (16)

Unknown

Research Site, Beijing

Research Site, Guangzhou

Research Site, Baoding

Research Site, Shijiazhuang

Research Site, Daqing

Research Site, Xinxiang

Research Site, Wuhan

Research Site, Suzhou

Research Site, Shenyang

Research Site, Shanghai

Research Site, Xijing

Research Site, Chengdu

Research Site, Tianjin

Research Site, Kuming

Research Site, Hangzhou

Research Site, Huzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY